Aging Gut Drives Bacteria Toward Harmful Pathoadaptive Mutations
E. coli evolving in very old mouse guts acquires pathoadaptive mutations tied to oxygen, iron, motility, and biofilm — even under healthy aging conditions.
Summary
Researchers tracked how a commensal E. coli strain evolved inside the guts of young, old, and very old laboratory mice over 24 days. Even under controlled, healthy conditions, E. coli colonizing very old mice (25 months) acquired mutations linked to pathoadaptation — adapting to oxygen and iron availability, increasing motility, and promoting biofilm formation. These mutations were largely absent in younger animals. Meanwhile, very old mice also showed enrichment of health-associated bacteria like Akkermansia muciniphila, suggesting a mixed picture of healthy aging alongside covert microbial pathoadaptation. The findings imply that aging itself, independent of diet or infection, may prime the gut environment to select for more dangerous microbial behaviors.
Detailed Summary
Understanding whether age-related gut microbial changes are a cause or consequence of aging is a central unresolved question in longevity research. This study addressed that question by using the gut as an evolutionary laboratory, tracking how a commensal Escherichia coli strain adapted across three age groups of laboratory mice — young (6–8 weeks), old (19 months), and very old (25 months) — over a 24-day colonization period under tightly controlled conditions.
Mice were treated with streptomycin to enable stable E. coli colonization and then inoculated with two isogenic E. coli strains marked by yellow or cyan fluorescent proteins. Shifts in marker frequency revealed the spread of beneficial mutations, allowing the team to reconstruct the selective pressures the aging gut exerts on resident bacteria. The frailty index confirmed progressive biological aging across cohorts, and fecal lipocalin-2 measurements showed elevated intestinal inflammation in both old and very old mice compared to young, though inflammation did not further escalate from old to very old — consistent with an inflammaging plateau.
16S rRNA microbiota profiling revealed distinct community compositions across age groups. Notably, the very old mice harbored enriched levels of Akkermansia muciniphila and short-chain fatty acid-producing taxa such as Oscillospira sp., a profile associated with healthy aging in humans. However, streptomycin had a disproportionately larger destabilizing effect on the microbiota of older cohorts, particularly depleting Bacteroidetes in old mice while certain S24-7 family members persisted in very old mice.
Despite colonizing at lower densities in older mice, E. coli evolved at similar rates across age groups. Crucially, mutations acquired exclusively in very old mice were predominantly pathoadaptive — tuning bacterial metabolism to exploit elevated oxygen and iron availability (features of an inflamed gut), enhancing motility via hyperflagellation, and promoting biofilm formation. Several mutations common to bacteria evolving in young mice were absent in the very old cohort, suggesting the aging gut environment suppresses certain commensal adaptations while selecting for traits associated with pathobiont behavior.
These findings support the hypothesis that healthy aging, even in the absence of disease or dietary stress, progressively reshapes gut selective pressures in ways that favor pathoadaptive bacterial evolution. The study is significant because it disentangles the effect of aging per se from confounding factors like diet and infection. It also highlights that standard markers of healthy aging (e.g., Akkermansia enrichment) can coexist with covert microbial pathoadaptation, underscoring the complexity of the aging microbiome.
Key Findings
- E. coli in very old mouse guts acquired pathoadaptive mutations related to oxygen/iron use, hypermotility, and biofilm formation.
- Mutations common in young-mouse E. coli were largely absent in very old animals, indicating age-specific selective pressures.
- Very old mice showed enrichment of Akkermansia muciniphila, consistent with healthy aging profiles seen in human centenarians.
- Intestinal inflammation (lipocalin-2) was elevated in both old cohorts but did not increase further from old to very old mice.
- Streptomycin-induced dysbiosis was strongest in old mice, while certain Bacteroidetes persisted in the very old cohort.
Methodology
Mouse cohorts (young 6–8 weeks, old 19 months, very old 25 months) were colonized with two isogenic fluorescently marked E. coli strains for 24 days following streptomycin treatment. Frailty index, fecal lipocalin-2, 16S rRNA microbiota profiling, and whole-genome sequencing of evolved E. coli isolates were used to assess host aging status, inflammation, microbiota composition, and bacterial adaptive mutations respectively.
Study Limitations
The study used a mouse model with artificially simplified colonization conditions (streptomycin pretreatment, single-strain inoculation), which may not fully recapitulate complex human gut ecology. The very old cohort was limited to 10 mice, reducing statistical power for certain comparisons. Findings are correlative regarding pathoadaptive mutation consequences — functional virulence assays were not performed to confirm pathogenic phenotypes.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: